Oncoplastic Breast Reconstruction

Written by Brian P. Kelley, MD — Dual Board-Certified Plastic & Hand Surgeon
Affiliate Faculty Professor, Dell Medical School at The University of Texas at Austin
Seton Ascension Institute for Reconstructive Plastic and Hand Surgery — Austin, Texas
‍Medically reviewed: May 3, 2026 · Last updated: May 31, 2026
Educational content. Not a substitute for individualized medical evaluation.

‍

What Is Oncoplastic Surgery?

Breast conservation therapy — lumpectomy followed by adjuvant radiation — is a standard treatment for early-stage breast cancer and a strong oncologic option for many patients. The trade-off, when it occurs, is cosmetic: removing breast tissue and irradiating what remains can leave a contour deformity, volume asymmetry, or visible retraction that develops months to years after treatment.

Oncoplastic surgery is the discipline that integrates the oncologic operation with reconstructive technique. The intent is either to prevent that deformity at the time of lumpectomy or to correct it later. Done well, it broadens the population of patients who can be safely offered breast conservation rather than mastectomy, and it produces better aesthetic outcomes than lumpectomy alone in patients who would otherwise face a meaningful contour deficit.

I practice as a dual board-certified plastic and hand surgeon in Austin, Texas, with academic appointments at Dell Medical School. Breast oncologic reconstruction is a defined part of my clinical practice, and I take referrals from across Central Texas for both immediate oncoplastic surgery and the correction of established post-radiation deformity. This page is the pillar guide to oncoplastic reconstruction: what it is, how it is classified, how it is performed, and what the outcomes data show.

The Two-Tier Classification of Oncoplastic Surgery

Oncoplastic techniques are not a single operation. They span a spectrum of complexity, and the field has developed classification systems to organize this spectrum for surgical planning, training, and patient counseling.

The most widely used framework was proposed by Clough and colleagues in 2010 and divides oncoplastic surgery into two levels based on the proportion of breast tissue removed and the technical complexity of the reconstruction.¹

Level I oncoplastic surgery involves resection of less than approximately 20% of the breast volume. The reconstruction uses tissue rearrangement of the ipsilateral breast — local tissue advancement, crescent mastopexy, donut mastopexy, or similar techniques — to close the lumpectomy defect and maintain breast contour. Level I procedures are within the scope of most breast surgical oncologists trained in oncoplastic technique.

Level II oncoplastic surgery involves resection of 20 to 50% of the breast tissue and uses more complex reconstructive techniques. These include therapeutic mammaplasty (using a formal breast reduction pattern to remove the tumor as part of a planned reduction), reduction mammaplasty designs, and volume replacement with local perforator flaps from the lateral chest wall. Level II procedures typically benefit from coordinated planning between the breast surgical oncologist and a plastic surgeon.

The American Society of Breast Surgeons proposed a parallel consensus classification in 2019 that aligns closely with Clough's framework while adding additional structure for shared decision-making and surgical training.²

These classifications matter because they shape who does what. Level I oncoplasty is often performed by breast surgical oncologists alone. Level II oncoplasty is where coordinated planning with plastic surgery typically adds value, and where the breast itself benefits from a reconstructive eye in the original operative plan.

When the Breast Surgeon Operates Alone, and When Plastic Surgery Joins

Breast surgical oncologists frequently perform lumpectomy and oncoplasty independently when the tumor is small relative to the breast, the resection margin is straightforward, and the predicted cosmetic result is acceptable. Standard lumpectomy in that setting is oncologically sound and is the right operation. Plastic surgery is consulted in those cases only if a deformity develops afterward.

Oncoplastic surgery as a coordinated operation becomes valuable when the predicted defect is large enough to deform the breast. This often happens when the tumor sits in an aesthetically demanding location like the upper inner quadrant, when the resection volume is a meaningful fraction of the breast, or when the patient already has features (large breasts, ptosis, asymmetry) that would benefit from a coordinated reconstructive plan.

In these cases, the breast surgical oncologist and the plastic surgeon plan the operation together. The cancer team prioritizes margins and nodal staging. The reconstructive team maps how to close the defect, where to recruit tissue from, and whether the contralateral breast needs a parallel procedure to maintain symmetry. Operating in parallel allows a larger tumor to be safely removed without a disfiguring result and preserves the option of breast conservation in patients who might otherwise be steered toward mastectomy.

Of note, I work closely with many oncology and breast surgeons who are specialty trained in oncoplasty and support them when necessary.
‍

Immediate Oncoplastic Reconstruction

When immediate oncoplastic reconstruction is indicated, the reconstruction happens in the same operation as the lumpectomy. This timing matters. The tissue has not yet been changed by radiation, native breast parenchyma is more elastic, the blood supply is intact, and tissue rearrangement behaves predictably.

The reconstructive options fall into two broad categories.

Displacement techniques mobilize and advance adjacent breast tissue into the lumpectomy defect, redistributing the remaining parenchyma to fill the cavity and reshape the breast. Specific operations include round-block (donut) mastopexy, batwing and crescent excisions for small superior tumors, and full reduction-pattern (Wise) techniques for larger resections in ptotic or macromastic breasts. Therapeutic mammaplasty — using a formal reduction pattern to encompass the tumor in a planned breast reduction — is one of the more powerful Level II displacement techniques.

Replacement techniques recruit tissue from outside the breast when there is not enough native parenchyma to redistribute. The most common options are local perforator flaps from the lateral chest wall: lateral intercostal artery perforator (LICAP) flaps, anterior intercostal artery perforator (AICAP) flaps, and thoracodorsal artery perforator (TDAP) flaps. These are pedicled flaps that bring tissue into the breast from the immediately adjacent area.

In my practice, I generally avoid recruiting tissue from areas outside the breast itself when possible, because in theory those donor areas could be exposed to cancer cells through the local environment and may then require radiation as well. Keeping the reconstruction within the breast unit, when feasible, minimizes the radiation field and the donor-site morbidity.

In both displacement and replacement approaches, contralateral symmetry procedures are often performed at the same operation. I'll discuss those separately below.

The Goldilocks Procedure

The Goldilocks procedure is a specific reconstructive approach that deserves its own discussion because it occupies a useful middle ground for a defined population of patients.

First described by Richardson and Ma in 2012, the Goldilocks procedure is a form of skin-sparing mastectomy in which the residual mastectomy flap — the redundant breast skin and subcutaneous tissue that would normally be discarded — is preserved and de-epithelialized to create an autologous breast mound.³ The name comes from the fairytale: the procedure is "just right" for a specific population — more aesthetic than a flat mastectomy without reconstruction, but simpler than implant reconstruction or microsurgical flap surgery.

The technique typically uses a Wise pattern (anchor-shaped) incision. The mastectomy is completed by the breast surgical oncologist, after which the inferior mastectomy flap is preserved, de-epithelialized, and folded onto itself to create a vascularized internal breast mound and a dermal sling for support. The remaining skin is then closed in a reduction-style pattern. An optional free nipple graft can be performed if the patient desires nipple preservation.

Who is the ideal candidate? The Goldilocks technique works best for patients with large, ptotic breasts who have meaningful redundant tissue available after mastectomy — most often patients with higher BMI.

Published series at the Mayo Clinic of 96 cases reported that the technique is safe and effective in patients with elevated BMI or excess local breast tissue, particularly when they prefer a single-stage reconstruction.⁴ A separate series of 58 patients reported on outcomes in high-risk reconstruction patients, with 82% of patients in that cohort being obese (mean BMI 36.8); the conclusion was that the technique is safe in this population, though many patients benefit from a subsequent secondary procedure to refine the aesthetic result.⁵

Who is not a good candidate? Patients with small breasts or thin habitus have limited tissue volume available for local contouring, and the Goldilocks technique has less to work with in those patients. Patients who need a large amount of skin removed from the upper pole of the breast also tend to do less well aesthetically.

Patient-reported outcomes. A recent scoping review found that BREAST-Q satisfaction scores after Goldilocks mastectomy were comparable to those reported after traditional reconstruction techniques in the populations studied.⁶ Complication rates in published series are comparable to traditional mastectomy techniques, with seroma, wound dehiscence, and fat necrosis being the most common.

A practical place in the algorithm. The Goldilocks procedure is particularly useful for three groups of patients: those who want some breast mound after mastectomy but do not want implants or microsurgical flap reconstruction; those with medical comorbidities (high BMI, diabetes, vascular disease, immunosuppression) that elevate the risk of more complex reconstruction; and those who would prefer a single-stage operation with shorter recovery.

Many patients undergoing Goldilocks reconstruction subsequently undergo staged refinement procedures — fat grafting, mastopexy, implant placement, or nipple reconstruction — to optimize the final aesthetic result. For the right patient, this is a meaningful option in the reconstructive conversation that many physicians don't routinely discuss.

Contralateral Symmetry Procedures

A coordinated reconstructive plan often includes a procedure on the unaffected breast to maintain or improve symmetry. This matters because radiation will subsequently change the treated side, and a single-sided reconstruction can drift out of alignment over time.

Contralateral symmetry options include a mastopexy (breast lift) to match the height and shape of the reconstructed side, a reduction mammaplasty to match a smaller reconstructed breast, an augmentation to match a fuller reconstructed breast, or a combination of these.

The Women's Health and Cancer Rights Act of 1998 (WHCRA) generally requires insurance coverage of contralateral symmetry procedures performed in connection with breast cancer reconstruction. I discuss the broader coverage landscape in a separate post on breast reconstruction coverage in Texas.

Symmetry procedures can be performed at the same time as the oncologic operation, at the time of a later staged reconstruction, or after radiation has stabilized. The right timing depends on the radiation plan and the trajectory of the treated breast.

Delayed Reconstruction After Radiation

Adjuvant radiation reduces local recurrence in breast conservation, and that benefit drives its routine use. The cost is a predictable set of changes in the irradiated tissue: progressive microvascular injury, cellular hypoxia, and fibrosis that develops over months to years. A lumpectomy site that looked acceptable at three months can become tethered, retracted, and discolored at three years.

When deformity emerges, surgical correction is possible — but it has to be timed correctly. Operating on irradiated tissue too early produces poor results. The acute inflammatory phase of radiation needs to resolve and the tissue needs to biologically calm before reconstruction is attempted.

In most patients this means a minimum of six to twelve months after the completion of radiation therapy, often longer, and the threshold is clinical rather than calendar-based. Operating before the tissue is ready raises the risk of wound healing problems, fat necrosis, and unsatisfactory results.

The radiation question shapes oncoplastic decision-making in a way I have addressed in published research. My first-authored systematic review on autologous reconstruction in the radiation setting in Annals of Surgical Oncology found a pooled flap fibrosis and contracture rate of approximately 27% with a stable overall complication profile.⁷ The companion review on implant-based reconstruction in the same setting found reconstruction failure rates approaching 20% in irradiated patients.⁸

These data inform how I counsel oncoplastic patients about realistic expectations for revision surgery in irradiated tissue. They also inform why durable reconstructive options in heavily irradiated patients lean toward autologous tissue rather than prosthetic solutions.

Autologous Fat Grafting in the Irradiated Breast

For most patients with established post-radiation deformity, autologous fat grafting is the workhorse of correction. The technique extends beyond simple volume restoration. Adipose tissue is harvested by low-pressure liposuction from a donor site — typically the abdomen or flanks — purified, and injected in microscopic aliquots into the subcutaneous and parenchymal layers of the irradiated breast.

What makes fat grafting particularly useful in this population is the regenerative biology of the graft itself. Adipose-derived stem cells and stromal vascular fraction components within the injected fat promote new blood vessel formation and modulate the local fibrotic response.

In practice, this means that fat grafting does more than fill a contour deficit. It softens contracted tissue, improves the quality of the overlying skin, and brings a measure of vascular health back into a field that has been depleted by radiation. Severe deformities typically require sequential, low-volume sessions spaced months apart — partly because the irradiated bed cannot reliably support large-volume single grafts, and partly because the regenerative effect on the tissue compounds over time.

Patient-Reported Outcomes

The patient-reported outcomes (PRO) literature on oncoplastic surgery has matured substantially over the past decade, with the BREAST-Q BCT module providing a validated instrument specifically designed for breast-conserving therapy patients. The available evidence is consistent in direction even though the studies vary in design.

A multicenter UK prospective cohort study (ANTHEM) of 362 women offered Level II oncoplastic breast-conserving surgery as an alternative to mastectomy found favorable BREAST-Q scores in the surgical group, with 82% of patients achieving clear margins on initial surgery and only 3.9% requiring completion mastectomy.⁹ A separate Swedish cohort found significantly better psychosocial well-being on BREAST-Q after oncoplastic surgery compared with conventional breast-conserving surgery (odds ratio 2.15 for above-median scores).¹⁰

A propensity-score-matched analysis of 297 patients (99 oncoplastic, 198 conventional) using long-term BREAST-Q data at three to five years post-operatively found favorable outcomes for the oncoplastic group across the relevant domains.¹¹ More recent prospective work in reproductive-age patients found 90% reporting satisfaction with their breasts in the oncoplastic group compared with 66% in the conventional breast-conserving group (p < 0.001).¹²

The honest summary across this body of evidence: in appropriately selected patients with experienced teams, oncoplastic surgery produces better patient-reported aesthetic and psychosocial outcomes than conventional breast-conserving surgery without compromising oncologic safety. The strongest predictors of a favorable outcome are appropriate patient selection, an experienced surgical team, and realistic expectations.

A separate but related observation worth flagging: my group at Dell Medical School recently published a systematic review on normal breast sensibility, evaluating what objective sensibility measurements look like in untreated breasts so the field can better interpret the results of reinnervation procedures performed during reconstruction.¹³ The honest framing from that work — that the field still lacks standardized normative measurements and that "restoring sensation" should be calibrated against realistic expectations — applies to oncoplastic reconstruction as well as to flap-based reconstruction.

What This Means for Patients

Oncoplastic reconstruction is not one operation. It is a category of approaches matched to a patient's tumor, breast anatomy, radiation plan, and goals.

Some patients benefit from immediate tissue rearrangement at the time of lumpectomy. Some are best served by independent lumpectomy with plastic surgery consultation reserved only for revision if a deformity develops. Some are candidates for the Goldilocks procedure as a middle-ground option after mastectomy. Many patients with established post-radiation deformity find that staged fat grafting produces a meaningfully better result than they had been told to expect.

The right path is determined by the cancer plan, the breast itself, and the timing of radiation — not by a one-size-fits-all algorithm. A thoughtful consultation involves the breast surgical oncologist, the radiation oncologist when relevant, and the reconstructive surgeon working as a team.

A Note on Local Care in Central Texas

Patients in Austin and across Central Texas facing breast cancer treatment deserve a coordinated team that considers reconstructive options at the time of cancer planning rather than only afterward. I work closely with breast surgical oncologists, medical and radiation oncologists, and patient navigators in the Central Texas region, and I take referrals for both immediate oncoplastic reconstruction and correction of established post-radiation deformity.

For patients without standard insurance coverage, I participate in the Travis County Medical Access Program (MAP) and the Seton charity care program. The available services for these patients are more limited than the full reconstructive spectrum, but oncoplastic options including some symmetry work and fat grafting can sometimes be offered.

‍

Medical References

1. Clough KB, Kaufman GJ, Nos C, Buccimazza I, Sarfati IM. Improving breast cancer surgery: a classification and quadrant per quadrant atlas for oncoplastic surgery. Annals of Surgical Oncology. 2010;17(5):1375–1391. PMID: 20140531.
2. Chatterjee A, Gass J, Patel K, et al. A consensus definition and classification system of oncoplastic surgery developed by the American Society of Breast Surgeons. Annals of Surgical Oncology. 2019;26(11):3436–3444. PMID: 31342359.
3. Richardson H, Ma G. The Goldilocks mastectomy. International Journal of Surgery. 2012;10(9):522–526. PMID: 22732431.
4. Chaudhry A, Oliver JD, Vyas KS, Alsubaie SA, Manrique OJ, Martinez-Jorge J. Outcomes analysis of Goldilocks mastectomy and breast reconstruction: A single institution experience of 96 cases. Journal of Surgical Oncology. 2019;119(8):1047–1052. PMID: 30950070.
5. Reece EM, et al. Outcomes of the Goldilocks Technique in High-Risk Breast Reconstruction Patients. Plastic and Reconstructive Surgery. 2023. PMID: 36862960.
6. ‍A scoping review of the Goldilocks mastectomy. 2025. PMCID: PMC12616074.
7. ‍Kelley BP, Ahmed R, Kidwell KM, Kozlow JH, Chung KC, Momoh AO. A systematic review of morbidity associated with autologous breast reconstruction before and after exposure to radiotherapy: are current practices ideal? Annals of Surgical Oncology. 2014;21(5):1732–1738. PMID: 24473643.
8. Momoh AO, Ahmed R, Kelley BP, Aliu O, Kidwell KM, Kozlow JH, Chung KC. A systematic review of complications of implant-based breast reconstruction with prereconstruction and postreconstruction radiotherapy. Annals of Surgical Oncology. 2014;21(1):118–124. PMID: 24081801.
9. ‍Clinical and patient-reported outcomes in women offered oncoplastic breast-conserving surgery as an alternative to mastectomy: ANTHEM multicentre prospective cohort study. 2024. PMCID: PMC11668256.
10. ‍Patient-reported outcome after oncoplastic breast surgery compared with conventional breast-conserving surgery in breast cancer. Scientific Reports. 2020. PMCID: PMC7031405.
11. ‍Long-Term Patient-Reported Outcomes Comparing Oncoplastic Breast Surgery and Conventional Breast-Conserving Surgery: A Propensity Score-Matched Analysis. Annals of Surgical Oncology. 2023. PMID: 37556008.
12. ‍Evaluation of level 2 oncoplastic breast surgery outcomes in patients of reproductive age using the BREAST-Q: A comparative analysis. Asian Journal of Surgery. 2025. (DOI 10.1016/j.asjsur.2025.05.024.)
13. Schafer HA, Leathers KO, Mumford KC, Ilangovan S, Vetter IL, Henry SL, Kelley BP, Torres-Guzman RA, Egeland BM. "Toward Breast Reinnervation — What is our Endpoint": A systematic review of normal breast sensibility. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2024;91:383–398. PMID: 38461623.
14. ‍Kelley BP, Valero V, Yi M, Kronowitz SJ. Tamoxifen increases the risk of microvascular flap complications in patients undergoing microvascular breast reconstruction. Plastic and Reconstructive Surgery. 2012;129(2):305–314. PMID: 21987043.
15. American Society of Plastic Surgeons. Breast Reconstruction Options. https://www.plasticsurgery.org/reconstructive-procedures/breast-reconstruction.
16. American Society of Breast Surgeons. Oncoplastic Surgery resources for surgeons and patients. https://www.breastsurgeons.org/.
17. Dr. Brian P. Kelley faculty profile, Dell Medical School, The University of Texas at Austin; Seton Institute of Reconstructive Plastic Surgery.

‍

Related Topics

• Breast Reconstruction Overview
• DIEP flap breast reconstruction
  
  • and my Blog Post on DIEP flap breast reconstruction
  • Differences Between DIEP Flap and TRAM Flap
  • DIEP Flap Recovery Guide
• Implants and Implant-based Reconstruction
  
  • Blog Post on Implant-based breast reconstruction
• Post-Mastectomy Breast Sensation
• Autologous Fat Grafting
• Lymphovenous Bypass and Lymphedema Prevention
• Facial and Mohs reconstruction
• Extremity reconstruction and limb salvage
• Lymphovenous Bypass for Post-Mastectomy Lymphedema
• Hybrid Breast Reconstruction
• Breast reconstruction after radiation: choosing a durable option
• Not a DIEP candidate? Alternative flaps for breast reconstruction
• Aesthetic flat closure
• Revising a breast reconstruction done in the past
• Breast reconstruction coverage in Texas: WHCRA and beyond
• Painful neuroma after prior surgery

Closing Disclaimer

This article is educational and does not establish a doctor-patient relationship. It does not substitute for individualized consultation, examination, or review of personal medical history and oncologic treatment plans. Patients considering oncoplastic breast reconstruction are encouraged to schedule a consultation to discuss their specific situation and reconstructive options.